Brain Tiger Technology: The company's "Sanquan" brain-machine interface product successfully completed its first clinical trial.

At the 2025 Tianqiao Brain Science Research Institute Brain-Machine Interface and Artificial Intelligence Forum held today, Brain Tiger Technology stated that the company's independently developed first domestic and second international implantable, wireless, and fully functional brain-machine interface product with built-in battery has successfully completed the first clinical trial under the leadership of Professor Ying Mao and Professor Liang Chen of the Fudan University-affiliated Huashan Hospital. The trial subject was a patient who had been completely paralyzed from the shoulders down for 8 years. The patient was transferred to a regular ward the day after the surgery, and successfully achieved mental control for the first time after 5 days. After systematic training, the patient's brain control decoding speed reached 5.2 BPS in standard tests, which is comparable to international top levels.